Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

You’re on our free ad-supported tier. Upgrade to NewsNow Essentials for just £4/m now! Your favourite news platform, faster, slicker and ad free.You’re on our free tier. Get NewsNow Essentials at just £4/m now!. Faster, slicker and ad free.You’re on our free tier. Go ad free for just £4/m now!

Home
Hot Topics
Nigeria
Politics
Crime
Premier League
Economy
Africa
World
Entertainment
Sport
La Liga
Serie A
Bundesliga
Lifestyle
Bitcoin
Cryptocurrencies
Sensational News

"CRISPR"
Topics

Advertisement

Advertisement

"CRISPR"

Showing articles that match "CRISPR" in the headline

In the last 8 hours

Wall Street Analysts Think CRISPR Therapeutics (CRSP) Is a Good Investment: Is It? Zacks 15:37

Yesterday

Meet Austin Jin, the 16-year-old Great Neck, New York student who built a CRISPR blood test to detect tuberculosis and drug resistance; he won $50,000 The Times of India 05:57 Wed, 16 Sep

AI-Assisted Design of Novel CRISPR/Cas Gene Editing Tools: Hype Vs Reality Organic Consumers Association 05:51 Wed, 16 Sep

Advertisement

Advertisement

Tuesday

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know Zacks 23:50 Tue, 15 Sep

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It Zacks 15:10 Tue, 15 Sep

CRISPR crops are coming to Europe — why bolder would be better Nature.com 10:25 Tue, 15 Sep

Monday

AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool 15:57 Mon, 14 Sep

Sunday

A CRISPR library points to oil-boosting genes in rapeseed Newswise (Press Release) 13:53 Sun, 13 Sep

Friday

Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool 16:14 Fri, 11 Sep

Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool 15:44 Fri, 11 Sep

Advertisement

In the last month

CRISPR’s Ability to Knock Down RNA May Be Artificially Inflated The Scientist 05:14 Thu, 10 Sep

Allergic to dogs? A CRISPR solution may be in the works Genetic Literacy Project 05:03 Thu, 10 Sep

A One Time CRISPR Infusion for Hereditary Angioedema Now Has a March Decision Date and No Advisory Panel Medical Daily 01:42 Thu, 10 Sep

Crispr fine-tuning unlocks vitamin C-rich potatoes without yield loss Newswise (Press Release) 15:58 Wed, 09 Sep

CRISPR therapy cuts cholesterol for at least 12 months Nature.com 11:54 Wed, 09 Sep

ESC 2026: Scăderea colesterolului LDL cu peste 50% se menține un an după administrarea unei terapii de editare genică CRISPR Raportul de gardă 08:51 Wed, 09 Sep

Why CRISPR Therapeutics Stock Rocked the Market Last Month The Motley Fool 22:48 Tue, 08 Sep

CRISPR Therapeutics (CRSP) Stock Looks Fully Priced Despite Stronger Pipeline Data Simply Wall St 21:26 Tue, 08 Sep

Where Will CRISPR Therapeutics Stock Be in 5 Years? The Motley Fool 16:21 Tue, 08 Sep

Julianna and Jacquere: New and Improved Genome-Wide CRISPR Knockout Libraries Addgene 14:23 Tue, 08 Sep

IntelliGenome Appoints Simed as Exclusive Distributor for CRISPR-TB™ in Peru and Ecuador PR Newswire (Press Release) 14:18 Tue, 08 Sep

Weekly reads: Stanford prof Mike Snyder & peptide cream, microglia aged out, CRISPR dogs, instrumented organoids The Niche (Weblog) 09:36 Sun, 06 Sep

2 Reasons CRISPR Therapeutics Stock Could Soar in the Final 4 Months of 2026 The Motley Fool 00:05 Thu, 03 Sep

Why Is CRISPR Therapeutics (CRSP) Up 7.1% Since Last Earnings Report? Zacks 17:39 Wed, 02 Sep

CRISPR–Cas regulates expression of embedded anti-phage defence systems Nature.com 16:11 Wed, 02 Sep

New Johns Hopkins Study Identifies Pervasive RT-qPCR Artifact in CRISPR Knockdown Studies and How UltraMarathonRT® Solves It PR Newswire (Press Release) 14:02 Wed, 02 Sep

VedaBio Selects Ucp Merchant Medicine to Position Its Target Amplification-Free CRISPR Molecular Diagnostics for Urgent Care Business Wire (Press Release) 12:01 Tue, 01 Sep

5 questions on CRISPR-Cas with Sandeep Rajan Sanger Institute Blog 08:55 Tue, 01 Sep

'One-pot' CRISPR platform delivers lab-like sensitivity in 30 minutes for at-home testing Phys.org 00:07 Tue, 01 Sep

New gene activation tool may do what CRISPR cannot: Work inside the body Phys.org 18:05 Mon, 31 Aug

CRISPR Therapeutics (CRSP) Stock May Look Rich Following Fresh CTX310 Data Simply Wall St 05:18 Sun, 30 Aug

What's New in Genome Editing: Takeaways from CRISPR Frontiers 2026 Addgene 14:20 Tue, 25 Aug

A CRISPR-based ‘dam-break drainage’ sensing architecture for rapid, affordable and ultrasensitive pathogen detection Nature.com 10:25 Sat, 22 Aug

CRISPR Therapeutics Stock Is Up Only 8% This Year. Is Cathie Wood's Bet on the Gene-Editing Stock Dead Money? The Motley Fool 16:10 Fri, 21 Aug

Photothermal nanomaterial-assisted multi-crRNA-enhanced one-tube RPA-CRISPR/Cas12a system for sensitive detection of Salmonella Typhimurium in milk Nature.com 09:40 Fri, 21 Aug

Recursion, Novavax and Crispr Stocks Trending in Pre-Market—Here's Why Benzinga 11:07 Thu, 20 Aug

CRISPR Kids | 60 Minutes Archive CBS News 23:32 Mon, 17 Aug

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Hot Topics Hot Topics
Nigeria Nigeria
Politics Politics
Crime Crime
Premier League
Economy Economy
Africa Africa
World World
Entertainment
Sport Sport
La Liga La Liga
Serie A Serie A
Bundesliga Bundesliga
Lifestyle Lifestyle
Bitcoin Bitcoin
Cryptocurrencies
Sensational News